TY  - GEN
AU  - Abdel-Mohsen, Mohamed
AU  - Richman, Douglas
AU  - Siliciano, Robert F
AU  - Nussenzweig, Michel C
AU  - Howell, Bonnie J
AU  - Martinez-Picado, Javier
AU  - Chomont, Nicolas
AU  - Bar, Katharine J
AU  - Yu, Xu G
AU  - Lichterfeld, Mathias
AU  - Alcamí, José
AU  - Hazuda, Daria
AU  - Bushman, Frederic
AU  - Siliciano, Janet D
AU  - Betts, Michael R
AU  - Spivak, Adam M
AU  - Planelles, Vicente
AU  - Hahn, Beatrice H
AU  - Smith, Davey M
AU  - Ho, Ya-Chi
AU  - Gaebler, Christian
AU  - Paiardini, Mirko
AU  - Li, Qingsheng
AU  - Estes, Jacob D
AU  - Hope, Thomas J
AU  - Kostman, Jay
AU  - Mounzer, Karam
AU  - Caskey, Marina
AU  - Fox, Lawrence
AU  - Frank, Ian
AU  - Riley, James L
AU  - Tebas, Pablo
AU  - Montaner, Luis J
AU  - Buzon, Maria J
PY  - 2020
DO  - 10.1038/s41591-020-1022-1
UR  - http://hdl.handle.net/20.500.12105/12088
AB  - Therapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will require a consensus on how best to measure the numbers of...
LA  - eng
PB  - Nature Publishing Group
KW  - HIV latency
KW  - HIV reservoirs
KW  - Viral measurements
KW  - HIV Cure
KW  - HIV persistence
KW  - Replication-competent HIV
KW  - Anti-Retroviral Agents
KW  - CD4-Positive T-Lymphocytes
KW  - Clinical Trials as Topic
KW  - Disease Reservoirs
KW  - HIV Infections
KW  - HIV-1
KW  - Humans
KW  - Mass Screening
KW  - Viral Load
KW  - Virus Latency
TI  - Recommendations for measuring HIV reservoir size in cure-directed clinical trials.
TY  - research article
ER  -